Ocular toxocariasis can cause distinctive cataracts

Article

Ocular toxocariasis can cause cataract with opacity similar to granuloma, claim recent findings published in the Journal of Cataract and Refractive Surgery.

Ocular toxocariasis can cause cataract with opacity similar to granuloma, claim recent findings published in the Journal of Cataract and Refractive Surgery.

Dr Seong Joon Ahn et al, Department of Ophthalmology, Seoul National Univeristy College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea, conducted a retrospective, observational case series on 83 patients presenting with ocular toxocariasis.

Ocular toxocariasis was clinically diagnosed based on retinal granuloma with or without ocular inflammation and positive results in serum antibody enzyme-linked immunosorbent assay. The team collected demographic and ocular examination data for all patients showing atypical cataract features. Each cataract was documented with anterior segment photography.

A total of 8.4% of the patients had an atypical cataract in the eye with ocular toxocariasis only. All patients presented with small, round, white lens opacities resembling retinal granulomas.

The granulomas were mainly located in the lens midperiphery and in the subcapsular level. The lens opacity could migrate, but only did so in one patient.

For the abstract please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.